RASCHI, ELENA
 Distribuzione geografica
Continente #
AS - Asia 2.393
NA - Nord America 2.393
EU - Europa 2.228
SA - Sud America 199
AF - Africa 56
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.281
Nazione #
US - Stati Uniti d'America 2.310
CN - Cina 803
SG - Singapore 778
GB - Regno Unito 774
IT - Italia 273
SE - Svezia 267
RU - Federazione Russa 246
HK - Hong Kong 214
DE - Germania 176
BR - Brasile 143
VN - Vietnam 134
FR - Francia 119
TR - Turchia 100
KR - Corea 86
UA - Ucraina 86
NL - Olanda 82
IN - India 76
IE - Irlanda 73
BD - Bangladesh 66
FI - Finlandia 66
CA - Canada 53
EU - Europa 48
JP - Giappone 32
ID - Indonesia 28
CI - Costa d'Avorio 26
CO - Colombia 25
MX - Messico 15
IQ - Iraq 13
AR - Argentina 11
BE - Belgio 11
GR - Grecia 11
UZ - Uzbekistan 8
AU - Australia 7
PK - Pakistan 6
SA - Arabia Saudita 6
VE - Venezuela 6
ZA - Sudafrica 6
BY - Bielorussia 5
KE - Kenya 5
RS - Serbia 5
AZ - Azerbaigian 4
CH - Svizzera 4
EC - Ecuador 4
ES - Italia 4
PH - Filippine 4
PL - Polonia 4
AT - Austria 3
CL - Cile 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
KW - Kuwait 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
NZ - Nuova Zelanda 3
OM - Oman 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BS - Bahamas 2
CR - Costa Rica 2
EG - Egitto 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
QA - Qatar 2
SO - Somalia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 7.317
Città #
Southend 713
Singapore 436
Chandler 285
Hong Kong 207
Ashburn 206
Beijing 188
San Jose 153
Seattle 128
Hangzhou 119
Princeton 109
Milan 99
Wilmington 82
Council Bluffs 77
Dublin 73
Santa Clara 71
Dallas 62
Los Angeles 60
Redmond 60
Phoenix 59
Dearborn 53
Nanjing 52
Lauterbourg 50
Bengaluru 46
Jacksonville 46
Mountain View 46
Sunnyvale 44
Ann Arbor 43
Des Moines 40
Ho Chi Minh City 40
Shanghai 38
Toronto 38
Grafing 37
Sakarya 37
Fairfield 35
Buffalo 31
Moscow 31
Woodbridge 31
Houston 30
New York 30
Somerville 28
Abidjan 26
Hanoi 26
Guangzhou 25
Serra 24
Tokyo 24
Bogotá 23
Andover 21
Boardman 21
Hefei 21
Jinan 20
Frankfurt am Main 18
Munich 18
Tianjin 17
Helsinki 16
São Paulo 16
Pisa 15
Shenzhen 15
The Dalles 15
Jakarta 13
Columbus 12
Falls Church 12
Hebei 12
Cambridge 11
Brussels 10
Shenyang 10
Athens 9
Cangzhou 9
Changsha 9
Harbin 9
Quanzhou 9
Rome 9
Seoul 9
Zhengzhou 9
Brooklyn 8
Chennai 8
Dong Ket 8
Eitensheim 8
Nanchang 8
Jiaxing 7
Tashkent 7
Turku 7
Biên Hòa 6
Chicago 6
Da Nang 6
Hamburg 6
San Diego 6
Turin 6
Gomel 5
Haikou 5
Haiphong 5
Johannesburg 5
Kiez 5
Nairobi 5
Norwalk 5
Rio de Janeiro 5
Verona 5
Auburn Hills 4
Baghdad 4
Baku 4
Bexley 4
Totale 4.684
Nome #
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 339
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 209
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs 209
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts 208
Antiphospholipid antibodies and the antiphospholipid syndrome : pathogenic mechanisms 202
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 198
Mechanisms of action of antiphospholipid antibodies 198
Endothelium as a target for antiphospholipid antibodies 196
Toll-like receptors : another player in the pathogenesis of the anti-phospholipid sindrome 193
Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation 180
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement 170
Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. 169
Effect of TNFalpha blocking agents on mRNA and miRNA profile in RA patients 165
Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement 164
Pathogenesis of antiphospholipid syndrome : understanding the antibodies 160
Toll-like receptor and antiphospholipid mediated thrombosis : in vivo studies 158
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease 150
TLR-4 and Annexin A2 involvement in pathogenic effects induced by anti-phospholipid antibodies is demonstrated by specific blocking agents and small interfering RNA in human endothelial cells 149
Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss : characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro 145
Antiphospholipid syndrome: not only an antibody-mediated disease 144
Endothelium activation in the anti-phospholipid syndrome 142
Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells 142
Relationship between sle susceptibility genes and clinical manifestations in a cohort of patients with primary antiphospholipid syndrome 140
Antiphospholipid antibodies and the endothelium 140
Chemerin serum levels in systemic sclerosis: a novel marker of early and active disease? 140
Humoral autoimmunity against endothelium : theory or reality? 138
Role of anti-beta(2) glycoprotein I antibodies in anti phospholipid syndrome : In vitro and in vivo studies 130
Anti-fibroblast antibodies in systemic sclerosis 130
Innate immunity in the antiphospholipid syndrome : role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies 129
Endothelial cell activation by antiphospholipid antibodies 129
Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention 127
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis 126
Obstetric and vascular APS : same autoantibodies but different diseases? 124
Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro 124
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts : differential effects in healthy and systemic sclerosis fibroblasts 123
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 120
Infectious origin of the antiphospholipid syndrome 118
Serum chemerin in systemic sclerosis : a novel marker of early diffuse disease? 118
Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies 117
Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway 112
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies 110
Update on the pathogenesis and treatment of the antiphospholipid syndrome 110
Mechanisms of Action of the Antiphospholipid Antibodies 110
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis 109
The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease 109
The challenges of lupus anticoagulants 106
Vitamin D and anti-phospholipid antibody syndrome : A comprehensive review 106
Anti-endothelial cell antibodies in patients with coronary atherosclerosis 104
Endothelium and the brain in CNS lupus 104
Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro 101
The story of the murine antiendothelial monoclonal antibody BGM. From patients' bedside to laboratory bench and from animal models to patients 94
Toll like receptors : a crossroad in scleroderma etiopathogenesis 94
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis 94
Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis 77
Totale 7.703
Categoria #
all - tutte 20.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 0 140 24
2021/2022406 46 13 7 9 12 23 43 18 55 41 18 121
2022/2023809 92 106 68 144 68 142 10 35 110 6 18 10
2023/2024325 10 27 41 28 77 16 4 5 6 16 44 51
2024/20251.107 32 127 22 120 87 25 15 106 62 93 96 322
2025/20262.107 249 140 226 169 230 146 253 126 202 213 153 0
Totale 7.703